RxDoctor Payments Data

Shanthi Sivendran, MD

Hematology & Oncology · Lancaster, PANPI 1699988147

Payments from drug & device makers

$23,544in general payments, 2019–2025

Across 24 payments — averaging $981.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$14K
  • AstraZeneca$5K
  • Merck$3K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Genentech USA, Inc.$150
  • Gilead$12

What the payments were for

  • Consulting fees$12,50856%
  • Travel & lodging$8,89440%
  • Food & beverage$8704%
  • Education$120%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$23,544 in reported general payments places this provider in the 65th percentile of 682 hematology & oncology providers in Pennsylvania.

See all hematology & oncology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$12,575
Medicare patients
68
Services billed
172

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole45$858
Ondansetron Hcl14$55

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →